Bluebird Lenti-D Data Give Gene Therapy Business Another Boost

Results Show Continued Positive Safety, Efficacy Profile

 
• By Alaric DeArment
  
Gene therapy
Bluebird announced positive follow-up data for Lenti-D in cerebral adrenoleukodystrophy. • Source: Shutterstock

More from Neurological

More from Therapy Areas